Jeffrey Petersen, MD, FRCP
Professor of Medicine
Clinical
Attends six months of the year on the inpatient consultative clinic. In addition he follows dialysis patients in satellite units , directs the inpatient dialysis unit, works in the transplant clinic and has several outpatient clinics.
Research Interests
Petersen has served as Principal Investigator for several studies of erythropoietin, including the effect on plasma levels of the route of delivery of erythropoietin during dialysis and the effect of dialysis on erythropoietin levels. He was Co-Investigator for the National Cooperative Study of recombinant human erythropoietin (rHuEPO) in chronic renal failure and a randomized study of the effects of exercise plus rHuEPO on physiological functioning and quality of life in hemodialysis patients.
Publications
- Pallone T, Myver S, Petersen J. Blood-dialysate equilibrium during continuous arteriovenous hemodialysis. Transactions of ASAIO 34, 512-514, 1988.
- Petersen J, Moore RM, Kaczmarek MD, Singh B, Yeh I, Hamburger S, Kankam M. The effects of reprocessing cuprophane and polysulfone dialyzers on b2-microglobulin removal from hemodialysis patients. Am J Kidney Dis 17, 174-178, 1991.
- Petersen J, Kang MS. In vivo effect of b2-microglobulin on bone resorption. Am J Kidney Dis. 23(5):726-730, May 1994.
- Pattison J, Petersen J, Kuo P, Valantine V, Robbins R, Theodore J. Renal failure in one hundred consecutive heart-lung transplant recipients. Am J Kidney Dis. 26:643-648, 1995.
- Fervenza F, Lafayette R, Alfrey E, and Petersen J. Renal artery stenosis in kidney transplants. Am J Kidney Dis. 31:142-148, 1998.